MTCH
53
3
VLO
33
3
AFL
41
4
PHM
60
6
PCG
77
3
V
56
2
TXT
59
6
ADBE
43
3
CAT
59
4
EQIX
60
3
WDC
44
3
JCI
45
4
NUE
51
3
DOV
61
4
RCL
81
4
MMM
30
2
LUV
40
2
CPB
30
5
AIV
51
4
EBAY
43
3
MTCH
53
3
VLO
33
3
AFL
41
4
PHM
60
6
PCG
77
3
V
56
2
TXT
59
6
ADBE
43
3
CAT
59
4
EQIX
60
3
WDC
44
3
JCI
45
4
NUE
51
3
DOV
61
4
RCL
81
4
MMM
30
2
LUV
40
2
CPB
30
5
AIV
51
4
EBAY
43
3
Financhill
Back

EyePoint Pharmaceuticals Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
56

EYPT
EyePoint Pharmaceuticals

Last Price:
12.05
Seasonality Move:
19.48%
Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
28.89
Seasonality Move:
22.1%
Buy
56
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $11.61. The Score for EYPT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $28.08. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $11.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $28.08
    The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 61.26 Buy
Chaikin Money Flow: 288172 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.64 - 11.44) Buy
Bollinger Bands (100): (8.05 - 10.13) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 45.96 Sell
Chaikin Money Flow: 8609149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.04 - 28.04) Buy
Bollinger Bands (100): (30.03 - 39.99) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.47 Buy
20-day SMA: 10.45 Buy
50-day SMA: 9.29 Buy
200-day SMA: 14.61 Sell
8-day EMA: 11.42 Buy
20-day EMA: 10.64 Buy
50-day EMA: 9.83 Buy
200-day EMA: 11.64 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.62 Buy
20-day SMA: 27.47 Buy
50-day SMA: 31.83 Sell
200-day SMA: 44.76 Sell
8-day EMA: 27.81 Buy
20-day EMA: 28.14 Sell
50-day EMA: 30.87 Sell
200-day EMA: 40.98 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.83 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.29 per share, and an increase next year of $1.33 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):